17.09.2021 | Letter to the Editor
Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease
Erschienen in: Endocrine | Ausgabe 2/2021
Einloggen, um Zugang zu erhalten